Sequana Medical NV (CHIX:SEQUAB) EV-to-Revenue : 53.42 (As of Jun. 07, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Sequana Medical NV EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sequana Medical NV's enterprise value is €44.98 Mil. Sequana Medical NV's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €0.84 Mil. Therefore, Sequana Medical NV's EV-to-Revenue for today is 53.42.

The historical rank and industry rank for Sequana Medical NV's EV-to-Revenue or its related term are showing as below:

CHIX:SEQUAb' s EV-to-Revenue Range Over the Past 10 Years
Min: 32.9 Med: 101.87 Max: 367.05
Current: 53.42

During the past 9 years, the highest EV-to-Revenue of Sequana Medical NV was 367.05. The lowest was 32.90. And the median was 101.87.

CHIX:SEQUAb's EV-to-Revenue is ranked worse than
94.2% of 827 companies
in the Medical Devices & Instruments industry
Industry Median: 3.1 vs CHIX:SEQUAb: 53.42

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-07), Sequana Medical NV's stock price is €6.16. Sequana Medical NV's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.04. Therefore, Sequana Medical NV's PS Ratio for today is 176.00.

Sequana Medical NV EV-to-Revenue Historical Data

The historical data trend for Sequana Medical NV's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV EV-to-Revenue Chart

Sequana Medical NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-Revenue

Get a 7-Day Free Trial

78.88

190.06

374.47

152.98

Sequana Medical NV Quarterly Data
	Dec15	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-Revenue	Get a 7-Day Free Trial									-	374.47	-	152.98	-

Competitive Comparison of Sequana Medical NV's EV-to-Revenue

For the Medical Devices subindustry, Sequana Medical NV's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sequana Medical NV's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sequana Medical NV's EV-to-Revenue falls into.

Sequana Medical NV EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sequana Medical NV's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	44.980	/	0.842
	=	53.42

Sequana Medical NV's current Enterprise Value is €44.98 Mil.
Sequana Medical NV's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.84 Mil.

Sequana Medical NV (CHIX:SEQUAb) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sequana Medical NV's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	6.16	/	0.035
	=	176.00

Sequana Medical NV's share price for today is €6.16.
Sequana Medical NV's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.04.

Sequana Medical NV EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequana Medical NV (CHIX:SEQUAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (CHIX:SEQUAb) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

2SE:Germany SEQUA:Belgium

Address

Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051

Website

https://www.sequanamedical.com

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (CHIX:SEQUAB) Headlines

No Headlines